USD730525S1 - Therapeutic gas delivery device - Google Patents

Therapeutic gas delivery device Download PDF

Info

Publication number
USD730525S1
USD730525S1 US29/467,025 US201329467025F USD730525S US D730525 S1 USD730525 S1 US D730525S1 US 201329467025 F US201329467025 F US 201329467025F US D730525 S USD730525 S US D730525S
Authority
US
United States
Prior art keywords
delivery device
gas delivery
therapeutic gas
therapeutic
view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/467,025
Inventor
Jaron Acker
Jarod Beukelman
Curtis Benjamin Irwin
Daniel J. Lee
Nicholas Scott Reback
Sarah Jayne Ridley
David Robert Strait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Pharma IP Trading DAC
Therakos Inc
Mallinckrodt Critical Care Finance Inc
Original Assignee
INO Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INO Therapeutics LLC filed Critical INO Therapeutics LLC
Priority to US29/467,025 priority Critical patent/USD730525S1/en
Assigned to CREDIT SUISSE AG, AS COLLATERAL AGENT reassignment CREDIT SUISSE AG, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: INO THERAPEUTICS LLC
Assigned to CREDIT SUISSE AG, AS COLLATERAL AGENT reassignment CREDIT SUISSE AG, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: INO THERAPEUTICS LLC
Assigned to INO THERAPEUTICS LLC reassignment INO THERAPEUTICS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RIDLEY, SARAH JAYNE, BEUKELMAN, Jarod, IRWIN, CURTIS BENJAMIN, LEE, DANIEL J., REBACK, NICHOLAS SCOTT, ACKER, Jaron, STRAIT, DAVID ROBERT
Assigned to IKARIA INC., INO THERAPEUTICS LLC reassignment IKARIA INC. RELEASE OF SECURITY INTEREST Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Assigned to INO THERAPEUTICS LLC reassignment INO THERAPEUTICS LLC RELEASE OF SECURITY INTEREST Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Assigned to CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT reassignment CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT PATENT SECURITY AGREEMENT (FIRST LIEN) Assignors: INO THERAPEUTICS LLC
Assigned to CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT reassignment CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT PATENT SECURITY AGREEMENT (SECOND LIEN) Assignors: INO THERAPEUTICS LLC
Assigned to INO THERAPEUTICS LLC reassignment INO THERAPEUTICS LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Assigned to INO THERAPEUTICS LLC reassignment INO THERAPEUTICS LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Assigned to DEUTSCHE BANK AG NEW YORK BRANCH reassignment DEUTSCHE BANK AG NEW YORK BRANCH SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INO THERAPEUTICS LLC
Publication of USD730525S1 publication Critical patent/USD730525S1/en
Application granted granted Critical
Assigned to MALLINCKRODT PHARMA IP TRADING DAC reassignment MALLINCKRODT PHARMA IP TRADING DAC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT CRITICAL CARE FINANCE INC.
Assigned to MALLINCKRODT IP reassignment MALLINCKRODT IP ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT PHARMA IP TRADING DAC
Assigned to Mallinckrodt Hospital Products IP Limited reassignment Mallinckrodt Hospital Products IP Limited ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT IP
Assigned to THERAKOS, INC. reassignment THERAKOS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INO THERAPEUTICS LLC
Assigned to MALLINCKRODT CRITICAL CARE FINANCE INC. reassignment MALLINCKRODT CRITICAL CARE FINANCE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THERAKOS, INC.
Assigned to DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT reassignment DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Assignors: Mallinckrodt Hospital Products IP Limited
Assigned to WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT reassignment WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT ARD IP LIMITED, Mallinckrodt Hospital Products IP Limited, MALLINCKRODT LLC, MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY, OCERA THERAPEUTICS, INC., SpecGx LLC, STRATATECH CORPORATION, Vtesse Inc.
Assigned to MALLINCKRODT LLC, MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED), VTESSE LLC (F/K/A VTESSE INC.), STRATATECH CORPORATION, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY), OCERA THERAPEUTICS, INC., SpecGx LLC, MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED) reassignment MALLINCKRODT LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Assigned to WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT reassignment WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT ENTERPRISES LLC, MALLINCKRODT LLC, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, OCERA THERAPEUTICS, INC., SpecGx LLC, STRATATECH CORPORATION, SUCAMPO PHARMA AMERICAS LLC, VTESSE LLC
Assigned to DEUTSCHE BANK AG NEW YORK BRANCH reassignment DEUTSCHE BANK AG NEW YORK BRANCH NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Assignors: MALLINCKRODT ENTERPRISES LLC, MALLINCKRODT LLC, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, OCERA THERAPEUTICS, INC., SpecGx LLC, STRATATECH CORPORATION, SUCAMPO PHARMA AMERICAS LLC, VTESSE LLC
Assigned to MALLINCKRODT ENTERPRISES LLC, VTESSE LLC, SUCAMPO PHARMA AMERICAS LLC, OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.), MALLINCKRODT LLC, SpecGx LLC, STRATATECH CORPORATION, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY reassignment MALLINCKRODT ENTERPRISES LLC RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Assignors: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Assigned to ACQUIOM AGENCY SERVICES LLC reassignment ACQUIOM AGENCY SERVICES LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MALLINCKRODT ENTERPRISES LLC, MALLINCKRODT LLC, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, OCERA THERAPEUTICS LLC, SpecGx LLC, STRATATECH CORPORATION, SUCAMPO PHARMA AMERICAS LLC, VTESSE LLC
Assigned to VTESSE LLC, MALLINCKRODT LLC, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, OCERA THERAPEUTICS, INC., SUCAMPO PHARMA AMERICAS LLC, SpecGx LLC, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY, STRATATECH CORPORATION, MALLINCKRODT ENTERPRISES LLC reassignment VTESSE LLC RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Assignors: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Assigned to MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.), MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, INFACARE PHARMACEUTICAL CORPORATION, MALLINCKRODT LLC, VTESSE LLC (F/K/A VTESSE INC.), MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED), OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.), THERAKOS, INC., LIEBEL-FLARSHEIM COMPANY LLC, SpecGx LLC, MALLINCKRODT INTERNATIONAL FINANCE S.A., MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED), STRATATECH CORPORATION, MALLINCKRODT CARRIBEAN, INC., MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.), CNS THERAPEUTICS, INC., INO THERAPEUTICS LLC, MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.), SUCAMPO PHARMA AMERICAS LLC, LAFAYETTE PHARMACEUTICALS LLC, MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.), LUDLOW LLC (F/K/A LUDLOW CORPORATION), MALLINCKRODT CB LLC, MALLINCKRODT ENTERPRISES LLC, MALLINCKRODT US HOLDINGS LLC, MEH, INC., MNK 2011 LLC (F/K/A MALLINCKRODT INC.), IKARIA THERAPEUTICS LLC, MALLINCKRODT US POOL LLC, ST SHARED SERVICES LLC, IMC EXPLORATION COMPANY, MALLINCKRODT VETERINARY, INC., MALLINCKRODT FINANCE GMBH reassignment MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.) RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 049822, FRAME 0674 Assignors: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Assigned to MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED), THERAKOS, INC., LIEBEL-FLARSHEIM COMPANY LLC, IKARIA THERAPEUTICS LLC, LAFAYETTE PHARMACEUTICALS LLC, MALLINCKRODT US POOL LLC, MALLINCKRODT FINANCE GMBH, MALLINCKRODT US HOLDINGS LLC, MALLINCKRODT INTERNATIONAL FINANCE S.A., ST SHARED SERVICES LLC, INFACARE PHARMACEUTICAL CORPORATION, MALLINCKRODT CARRIBEAN, INC., MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.), MALLINCKRODT ENTERPRISES LLC, MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.), VTESSE LLC (F/K/A VTESSE INC.), CNS THERAPEUTICS, INC., MALLINCKRODT CB LLC, MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.), MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.), MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED), OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.), SpecGx LLC, MALLINCKRODT VETERINARY, INC., STRATATECH CORPORATION, MNK 2011 LLC (F/K/A MALLINCKRODT INC.), MEH, INC., LUDLOW LLC (F/K/A LUDLOW CORPORATION), MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED, INO THERAPEUTICS LLC, MALLINCKRODT LLC, IMC EXPLORATION COMPANY, SUCAMPO PHARMA AMERICAS LLC reassignment MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED) RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 035454, FRAME 0768 Assignors: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a front top right perspective view of a therapeutic gas delivery device;
FIG. 2 is a front view of a therapeutic gas delivery device;
FIG. 3 is a top view of a therapeutic gas delivery device;
FIG. 4 is a back view of a therapeutic gas delivery device;
FIG. 5 is a bottom view of a therapeutic gas delivery device;
FIG. 6 is a right view of a therapeutic gas delivery device; and,
FIG. 7 is a left view of a therapeutic gas delivery device.
In the drawings, the broken lines depict environmental subject matter only and form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a therapeutic gas delivery device, substantially as shown and described.
US29/467,025 2013-09-13 2013-09-13 Therapeutic gas delivery device Active USD730525S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/467,025 USD730525S1 (en) 2013-09-13 2013-09-13 Therapeutic gas delivery device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/467,025 USD730525S1 (en) 2013-09-13 2013-09-13 Therapeutic gas delivery device

Publications (1)

Publication Number Publication Date
USD730525S1 true USD730525S1 (en) 2015-05-26

Family

ID=53176964

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/467,025 Active USD730525S1 (en) 2013-09-13 2013-09-13 Therapeutic gas delivery device

Country Status (1)

Country Link
US (1) USD730525S1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD776279S1 (en) * 2015-10-30 2017-01-10 Mallinckrodt Hospital Products IP Limited MRI compatible therapeutic gas delivery cart
USD875255S1 (en) * 2018-05-30 2020-02-11 Avent, Inc. Radiofrequency ablation pump
USD882068S1 (en) * 2016-04-19 2020-04-21 Xenios Ag Gas exchange medical apparatus
USD888959S1 (en) * 2017-02-03 2020-06-30 Zsolt Zoltan Berta Gas therapy seating apparatus for transcutaneous treatment
USD889659S1 (en) * 2014-02-19 2020-07-07 RedMed Pty Ltd Positive airway pressure delivery console
USD900323S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Single head pump unit
USD900321S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Radiofrequency ablation pump assembly
USD900322S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Radiofrequency ablation pump and generator assembly
USD939080S1 (en) * 2019-09-27 2021-12-21 Fujifilm Corporation Water supplying machine for endoscope
USD948030S1 (en) * 2019-09-27 2022-04-05 Fujifilm Corporation Water tank for use in water supplying machine for endoscope

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Final Office Action in U.S. Appl. No. 29/467,028, dated Oct. 14, 2014, 7 pgs.
Non-Final Office Action in U.S. Appl. No. 29/467,028, dated Mar. 27, 2014, 9 pgs.

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD889659S1 (en) * 2014-02-19 2020-07-07 RedMed Pty Ltd Positive airway pressure delivery console
USD1010130S1 (en) 2014-02-19 2024-01-02 ResMed Pty Ltd Positive airway pressure delivery console
USD776279S1 (en) * 2015-10-30 2017-01-10 Mallinckrodt Hospital Products IP Limited MRI compatible therapeutic gas delivery cart
USD807510S1 (en) * 2015-10-30 2018-01-09 Mallinckrodt Hospital Products IP Limited MRI compatible therapeutic gas delivery cart
USD882068S1 (en) * 2016-04-19 2020-04-21 Xenios Ag Gas exchange medical apparatus
USD888959S1 (en) * 2017-02-03 2020-06-30 Zsolt Zoltan Berta Gas therapy seating apparatus for transcutaneous treatment
USD875255S1 (en) * 2018-05-30 2020-02-11 Avent, Inc. Radiofrequency ablation pump
USD900323S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Single head pump unit
USD900321S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Radiofrequency ablation pump assembly
USD900322S1 (en) * 2018-12-28 2020-10-27 Avent, Inc. Radiofrequency ablation pump and generator assembly
USD939080S1 (en) * 2019-09-27 2021-12-21 Fujifilm Corporation Water supplying machine for endoscope
USD948030S1 (en) * 2019-09-27 2022-04-05 Fujifilm Corporation Water tank for use in water supplying machine for endoscope

Similar Documents

Publication Publication Date Title
USD729936S1 (en) Therapeutic gas delivery device
USD725310S1 (en) Vaporizer
USD771308S1 (en) Vaporizer
USD737276S1 (en) Protective case for electronic tablet
USD729440S1 (en) Atomizing device
USD743192S1 (en) Table
USD720041S1 (en) Spray device
USD735314S1 (en) Aromatherapy diffuser
USD692547S1 (en) Aroma-diffusing apparatus
USD750986S1 (en) Main body for a data logger
USD703343S1 (en) Sterilizer
USD765488S1 (en) Fitting for furniture
USD747924S1 (en) Infuser
USD692551S1 (en) Aroma-diffusing apparatus
USD730525S1 (en) Therapeutic gas delivery device
USD718358S1 (en) Torch
USD727511S1 (en) Breathing device
USD703251S1 (en) Torch
USD731217S1 (en) Table
USD701963S1 (en) Therapeutic gas delivery device
USD759650S1 (en) Tablet learning device
USD711669S1 (en) Pillow
USD696510S1 (en) Umbrella
USD710639S1 (en) Chair
USD699490S1 (en) Dresser

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY